About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
RWCS 2021 Highlights on Biologics/tsDMARDs: What Are the Commonly Considered Potential Safety Issues? What Is the Lymphoma Incidence in RA & Risk for VTE?
By
RWCS
FEATURING
Arthur Kavanaugh
,
John J. Cush
By
RWCS
FEATURING
Arthur Kavanaugh
,
John J. Cush
208 views
April 9, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Related Content
AUTOPLAY
ON
19:49
Rush University Medical Center
COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…
Feat.
S. Jain
18:41
CHEST 2022 Coverage
Role of Anticoagulants and Antiplatelet Agents for Patients With COV…
Feat.
V. Balasubramanian
21:20
Cleveland Clinic Rheumatology
How do I Recognize and Treat the VEXAS Syndrome?
Feat.
P. Grayson
22:08
RheumNow
RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…
Feat.
J. Cush
31:18
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023
Thrombosis and Anticoagulation: 2023 Update
Feat.
S. Moll
26:31
Cleveland Clinic Rheumatology
Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…
Feat.
R. Q. Cron
25:25
Keck School of Medicine of USC
Update on the New ANA Classification System
Feat.
E. Taylor-Albert
13:16
ASH 2022 Conference Coverage
Experts Discuss Key Updates in CLL
Feat.
S. O'Brien,
C. Coombs
27:14
2024 Clinical Case Studies
Clinical Case Review: Cutaneous T Cell Lymphoma in the Patch Test Cl…
Feat.
J. Murase
28:10
Indy Hematology Review
Current Review of Benign Hematology and Coagulopathy
Feat.
C. Kessler
25:16
Cleveland Clinic Rheumatology
Integrative Health Approaches for Optimum Immune Health
Feat.
C. Wang
10:35
Alan Skarbnik
Learnings From the ELEVATE-TN Phase 3 Trial: Acalabrutinib+/-Obinutu…
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
13:36
Vanderbilt University Medical Center (VUMC)
Venous Thromboembolism Prophylaxis in Newly Diagnosed MM
Feat.
M. Baljevic
28:59
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
Management of Simultaneous Venous and Arterial Thromboembolic Disease
Feat.
J. May
10:27
Robert McBane
2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…
56:29
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Update in Thromboembolism
Feat.
D. Garcia
51:20
Jerry Spivak
Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…
04:14
ecancer
ALPINE: A Randomized Phase 3 Study of Zanubrutinib vs. Ibrutinib for…
Feat.
J. Brown
25:56
UChicago Medicine
ASH Annual Meeting Updates in Non-Malignant/Classical Hematology
Feat.
K. Cohen
